Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Spectrum Pharmaceuticals
Lobbying Relationship
Bills mentioned
S.296: Preserving Access to Life-Saving Medications Act
Sponsor: Amy Klobuchar (D-Minn.)
H.R.2245: Preserving Access to Life-Saving Medications Act of 2011
Sponsor: Diana DeGette (D-Colo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Brian Carey | Professional staff, Senate Committee on Labor |
| Dayle Lewis Cristinzio | Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg |
| Paul Kim | Senator Kennedy Director For Health Policy; Congressman |
| - - | Waxman counsel; Senator Pryor Staff on Health, Education, Labor and Pensions Asst; Sen Charles Schumer, Dir Econ Dev&Approp and Human Resources Congressman Waxman counsel; Senator Pryor |
| Stacey Sachs | Health Counsel to the U.S. Senate Committee |
| Rodger Currie | n/a |
| Kevin Brennan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate